Patent · US Active

Detection of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in biological samples

US7888075B2 · kind B2 · utility

5Cited by
11References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2008
Grant dateFeb 15, 2011
Priority date
Expiry dateDec 7, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are methods of identifying a methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-sensitive Staphylococcus aureus (MSSA) in a sample. The present invention provides a diagnostic method comprising modification of sequences of S. aureus by converting non-methylated cytosine residues ultimately into thymidine residues in the target nucleic acid. The invention further provides for the detection of modified sequences derived from the spa gene, the mecA gene, and the integrated SCCmec cassette of S. aureus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.